Judith Neugroschl

A randomized, double‐blind, placebo‐controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study

Carolyn W. Zhu, Hillel Grossman, Judith Neugroschl et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · 118 citations · Full text

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer et al. · The Lancet Neurology · 2021 · 108 citations

Neurodegenerative Diseases, Neuropsychology, Alzheimer's Disease +11

The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults

Clara Li, Judith Neugroschl, Xiaodong Luo et al. · Journal of Alzheimer s Disease · 2017 · 83 citations · Full text

The Development and Piloting of a Capacity Assessment Tool

Maria Torroella Carney, Judith Neugroschl, R. Sean Morrison et al. · The Journal of Clinical Ethics · 2001 · 53 citations

Capacity Assessment Tool, Engineering, Project Management +7

The Caregiver Activity Survey (CAS): longitudinal validation of an instrument that measures time spent caregiving for individuals with Alzheimer's disease

Deborah B. Marin, Micheline Dugue, James Schmeidler et al. · International Journal of Geriatric Psychiatry · 2000 · 38 citations · Full text